1-4 of 4
Fangli Chen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative Analysis of AML Cell Response to Cytarabine Reveals Synergistic Opportunities Centered on Cholesterol Metabolism

Fangli Chen, MD PhD, Xue Wu, PhD, Rogozea Adriana, Bin Guo, PhD, H. Scott Boswell, MD, George A. Calin, MD PhD, Mircea Ivan, MD PhD, Heiko Konig, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2631.
https://doi.org/10.1182/blood-2018-99-113634
Published: 2018
Journal Articles

Inhibition of Carbonic Anhydrase-IX As a Novel Strategy to Overcome Hypoxia Mediated Drug Resistance in FLT3/ITD Mutated Acute Myeloid Leukemia

Fangli Chen, MD PhD, Adriana Rogozea, George Sandusky, DVM, PhD, Mircea Ivan, MD PhD, Heiko Konig, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2521.
https://doi.org/10.1182/blood.V130.Suppl_1.2521.2521
Published: 2017
Journal Articles

Development of FF-10101, a Novel Irreversible FLT3 Inhibitor, Which Overcomes Drug Resistance Mutations

Toshiyuki Nakatani, PhD, Ken Uda, Takeshi Yamaura, Masaru Takasaki, Akimi Akashi, Fangli Chen, MD, Yuichi Ishikawa, MDPhD, Fumihiko Hayakawa, MD PhD, Shinji Hagiwara, PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1353.
https://doi.org/10.1182/blood.V126.23.1353.1353
Published: 2015
Journal Articles

Mechanism of FLT3 Ligand Dependent Resistance to FLT3 Inhibitors

Fangli Chen, MD, Yuichi Ishikawa, MD,PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MDPhD
Journal: Blood
Blood (2014) 124 (21): 908.
https://doi.org/10.1182/blood.V124.21.908.908
Published: 2014